| ADMA | Asymmetric dimethylarginine |
| AST | aspartate aminotransferase |
| BDL | Bile duct ligation |
| BDL + T | Bile duct ligation + Treatment (L-NAME) |
| cNOS | constitutively expressed NOS |
| DAB | 3,3-Diaminobenzidine |
| ECM | Extracellular matrix |
| EMT | Epithelial-to-mesenchymal transition |
| eNOS | Endothelial NOS |
| HA | Hyaluronic acid |
| HIF-1α | Hypoxia-inducible factor-1α |
| HSC | Hepatic stellate cells |
| IF | Immunofluoresence |
| IHC | Immunohistochemistry |
| IL-6 | Interleukin 6 |
| iNOS | Inducible NOS |
| IRI | Ischemia–reperfusion injury |
| L-NAME | N-Nitroarginine methyl ester |
| MDA | Malondialdehyde |
| mRNA | Messenger ribonucleic acid |
| nNOS | Neuronal NOS |
| NO | Nitric oxide |
| NOS | NO synthase(s) |
| PM | Pringle maneuver |
| PVF | Portal venous flow |
| RT-qPCR | Quantitative real-time polymerase chain reaction |
| RECA-1 | Rat endothelial cell antigen-1 |
| TGF-β | Transforming growth factor β |